📰 Berkeley Lights Beacon News
Berkeley Lights Beacon News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Berkeley Lights Beacon. Real-time updates on events, politics, business and more.
November 9, 2022
/PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Monash University, one of Australias leading...
November 9, 2022
/PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Monash University, one of Australias leading...
August 4, 2022
/PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and the Jaime Leandro Foundation for Therapeutic Cancer Vaccines (JLF),...
December 2, 2021
EMERYVILLE, Calif. and MARSEILLE, France, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and MImAbs SAS, an emerging CRO that discovers
November 5, 2021
BLI earnings call for the period ending September 30, 2021.
May 25, 2021
The new partnership between Berkeley Lights, a digital cell biology company, and Genovac, an antibody discovery company, exemplifies how to use industry collaboration to find elusive answers to some of the biggest problems in antibody therapy.
January 12, 2021
(2) EMERYVILLE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto Plasma B Discovery 4.0 workflow. Opto Plasma B Discovery 4.0 is the industrys premier antibody discovery workflow by advancing from B cells to lead molecules in just 1 week. This workflow enables our customers to: Sample 4x more of the relevant biodiversity, screening up to 100,000 cells Functionally test with highly sensitive cell-based ass...